IDiyas

For the Inventor, By the Inventor

Ohtsu, Japan

Takahiro Nakajima

USPTO Granted Patents = 10


Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 62(Granted Patents)


Location History:

  • Ohtsu, JP (2006 - 2012)
  • Chiyoda-ku, JP (2020 - 2022)

Company Filing History:

goldMedal7 out of 789 
 
Toyo Boseki Kabushiki Kaisha
 patents
silverMedal3 out of 45 
 
Kyowa Kirin Co., Ltd.
 patents

Years Active: 2006-2022

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 11447471 - α,β-unsaturated amide compound (2022-09-20),
2. 11332455 - α,β-unsaturated amide compound (2022-05-17),
3. 10787428 - α,β-unsaturated amide compound (2020-09-29),
4. 8293862 - Polyester polymerization catalyst, polyester produced by using the same, and a process for producing polyester (2012-10-23),
5. 7868126 - Process for producing polyester, polyester produced using said process, and polyester molded product (2011-01-11),
6. 7501373 - Polymerization catalyst for polyester production, polyester, and process for producing polyester (2009-03-10),
7. 7208565 - Polymerization catalyst for polyesters, polyester produced with the same, and process for production of polyester (2007-04-24),
8. 7199212 - Polymerization catalyst for polyesters, polyesters produced with the same and process for producing polyesters (2007-04-03),
9. 7144614 - Polyester polymerization catalyst, polyester produced by using the same, and process for producing polyester (2006-12-05),
10. 7132383 - Polymerization catalyst for polyester, polyester produced with the same, and process for producing polyester (2006-11-07),

Title: The Innovative Contributions of Takahiro Nakajima

Introduction

Takahiro Nakajima is a prominent inventor based in Ohtsu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticancer activity. With a total of 10 patents to his name, Nakajima's work continues to impact the medical community.

Latest Patents

One of Nakajima's latest patents involves an α,β-unsaturated amide compound. The objective of this invention is to provide a compound or a pharmaceutically acceptable salt that exhibits anticancer activity. The compound is represented by a specific formula, where 'A' denotes an optionally substituted heterocyclic diyl. This innovation aims to enhance therapeutic options for cancer treatment.

Career Highlights

Throughout his career, Takahiro Nakajima has worked with notable companies, including Toyo Boseki Kabushiki Kaisha and Kyowa Kirin Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Some of Nakajima's coworkers include Shoichi Gyobu and Mitsuyoshi Kuwata. Their collaborative efforts have likely played a role in advancing the research and development of innovative compounds.

Conclusion

Takahiro Nakajima's contributions to the field of pharmaceuticals, particularly through his patents on α,β-unsaturated amide compounds, highlight his role as a significant inventor. His work continues to pave the way for advancements in cancer treatment and showcases the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…